AIDX 20/20 Biolabs, Inc. - Common Stock

NASDAQ · · View on SEC EDGAR ↗
$0.54
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026
52W Range
$0–$50
0% of range
Analyst Rating
BUY
7 analysts
Price Target
$5
+826% upside
P/E (TTM)
—
ROE
-503.1%
Net Profit Margin
-182.8%

AIDX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.54
Market Cap
—
P/E (TTM)
—
EPS (TTM)
$-0.76
Revenue (TTM)
$2M
Div Yield
—
ROE
-503.1%
Debt/Equity
—
52W Range
$0 – $50

AIDX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $2M
2-point trend, +16.7%
2024-12-31 → 2025-12-31
EPS $-0.76
2-point trend, +34.5%
2024-12-31 → 2025-12-31
Free Cash Flow —
Margins -182.8%
2025-12-31 → 2025-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
AIDX
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
AIDX
Peer Median
Gross Margin
29.6%
—
Operating Margin
-162.9%
—
Net Profit Margin
-182.8%
—
ROA
-96.8%
—
ROE
-503.1%
—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
AIDX
Peer Median
Current Ratio
0.6
—
Quick Ratio
0.5
—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
AIDX
Peer Median
Revenue YoY
2-point trend, +16.7%
16.7%
—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
AIDX
Peer Median
EPS (Diluted)
2-point trend, +34.5%
$-0.76
—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
AIDX
Peer Median

AIDX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-16
Median target $5.00 +825.9%
Mean target $5.00 +825.9%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
AIDX — — 16.7% -182.8% -503.1% 29.6%
ADVB $15M -4.4 — — -159.1% —
NXGL — — — — — —
LUCY — — — — — —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 15
Annual Income Statement data for AIDX
Metric Trend 20252024
Revenue 2-point trend, +16.7% $2M $2M
Cost of Revenue 2-point trend, +3.5% $1M $1M
Gross Profit 2-point trend, +67.8% $604.5K $360.3K
R&D Expense 2-point trend, -53.0% $592.6K $1M
SG&A Expense 2-point trend, -29.8% $3M $5M
Operating Expenses 2-point trend, -34.8% $4M $6M
Operating Income 2-point trend, +41.3% $-3M $-6M
Interest Income 2-point trend, -73.1% $21.4K $79.5K
Other Non-op 2-point trend, -100.2% $-115 $58.9K
Net Income 2-point trend, +32.7% $-4M $-6M
EPS (Basic) 2-point trend, +34.5% $-0.76 $-1.16
EPS (Diluted) 2-point trend, +34.5% $-0.76 $-1.16
Shares (Basic) 2-point trend, +2.7% 4,930,287 4,800,524
Shares (Diluted) 2-point trend, +2.7% 4,930,287 4,800,524
EBITDA $-3M ·
Balance Sheet 22
Annual Balance Sheet data for AIDX
Metric Trend 20252024
Cash & Equivalents 2-point trend, -42.5% $1M $2M
Receivables 2-point trend, +47.8% $200.0K $135.3K
Inventory 2-point trend, +146.4% $116.2K $47.2K
Prepaid Expense 2-point trend, +90.3% $129.0K $67.8K
Current Assets 2-point trend, -27.7% $1M $2M
PP&E (Net) 2-point trend, -51.4% $56.7K $116.7K
PP&E (Gross) Flat — no change across 2 periods $581.2K $581.2K
Accum. Depreciation 2-point trend, +12.9% $524.6K $464.6K
Intangibles 2-point trend, -1.6% $202.3K $205.5K
Other Non-current Assets 2-point trend, -85.8% $23.1K $162.0K
Total Assets 2-point trend, +15.4% $4M $4M
Accounts Payable 2-point trend, +133.3% $868.5K $372.3K
Accrued Liabilities 2-point trend, +126.7% $785.8K $346.6K
Current Liabilities 2-point trend, +81.8% $2M $1M
Capital Leases 2-point trend, -27.5% $488.7K $673.8K
Total Liabilities 2-point trend, +99.9% $4M $2M
Common Stock 2-point trend, +12.8% $54.4K $48.2K
Paid-in Capital 2-point trend, +7.0% $33M $31M
Retained Earnings 2-point trend, -12.7% $-33M $-30M
Stockholders' Equity 2-point trend, -101.3% $-19.2K $2M
Liabilities + Equity 2-point trend, +15.4% $4M $4M
Shares Outstanding 2-point trend, +12.8% 5,442,249 4,823,125
Cash Flow 7
Annual Cash Flow data for AIDX
Metric Trend 20252024
D&A 2-point trend, -45.5% $63.3K $116.0K
Stock-based Comp 2-point trend, -76.3% $516.2K $2M
Amort. of Intangibles Flat — no change across 2 periods $22.5K $22.5K
Other Non-cash $1M ·
Operating Cash Flow 2-point trend, +26.1% $-2M $-3M
Financing Cash Flow 2-point trend, +296.0% $1M $293.3K
Net Change in Cash 2-point trend, +67.1% $-758.0K $-2M
Profitability 6
Annual Profitability data for AIDX
Metric Trend 20252024
Gross Margin 29.6% ·
Operating Margin -162.9% ·
Net Margin -182.8% ·
EBITDA Margin -159.8% ·
ROA -96.8% ·
ROE -503.1% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for AIDX
Metric Trend 20252024
Current Ratio 0.6 ·
Quick Ratio 0.5 ·
Efficiency 3
Annual Efficiency data for AIDX
Metric Trend 20252024
Asset Turnover 0.5 ·
Inventory Turnover 17.6 ·
Receivables Turnover 12.2 ·
Per Share 5
Annual Per Share data for AIDX
Metric Trend 20252024
Book Value / Share $-0.00 ·
Revenue / Share $0.41 ·
Cash Flow / Share $-0.39 ·
Cash / Share $0.19 ·
EPS (TTM) $-0.76 ·
Growth Rates 1
Annual Growth Rates data for AIDX
Metric Trend 20252024
Revenue YoY 16.7% ·
Valuation (TTM) 2
Annual Valuation (TTM) data for AIDX
Metric Trend 20252024
Revenue TTM $2M ·
Net Income TTM $-4M ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-31
Revenue $2M$2M
Gross Margin % 29.6%—
Operating Margin % -162.9%—
Net Income $-4M$-6M
Diluted EPS $-0.76$-1.16
Balance Sheet
2025-12-312024-12-31
Current Ratio 0.6—
Quick Ratio 0.5—

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 15 filers · $248K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
10 2 2 3 —

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.

Institution Value Shares % of tracked 13F Type
Cresset Asset Management, LLC $131,995 240,122 53.19% Shares
VANGUARD FIDUCIARY TRUST CO $28,648 52,087 11.54% Shares
GEODE CAPITAL MANAGEMENT, LLC $27,012 49,141 10.88% Shares
Atlantic Union Bankshares Corp $19,294 35,099 7.77% Shares
VANGUARD CAPITAL MANAGEMENT LLC $13,492 24,530 5.44% Shares
CITADEL ADVISORS LLC $12,756 23,205 5.14% Shares
BANK OF AMERICA CORP /DE/ $7,150 13,024 2.88% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $5,505 10,014 2.22% Shares
MCDONALD PARTNERS LLC $1,539 2,800 0.62% Shares
SIGNATUREFD, LLC $422 767 0.17% Shares
MORGAN STANLEY $156 283 0.06% Shares
Allworth Financial LP $95 172 0.04% Shares
TOTH FINANCIAL ADVISORY CORP $55 100 0.02% Shares
HRT FINANCIAL LP $49 89,273 0.02% Shares
UBS Group AG $2 3 0.00% Shares

Company insiders 7 insiders · 3 officers · 5 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Jonathan M Cohen Chief Executive Officer March 3, 2026 A — 0 0 $0
Alan B. Bergman Chief Financial Officer April 2, 2026 A — 0 0 $0
Jiming Zhou Chief Operating Officer April 2, 2026 A — 0 0 $0
John Woodson Rollins Director Feb. 19, 2026 C 30,275 0 0 $0
Michael A. Ross Director Feb. 19, 2026 C 31 0 0 $0
John G. Compton Director Feb. 19, 2026 C 14,335 0 0 $0
COHEN RICHARD M Director Feb. 19, 2026 C 7,700 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Jonathan M Cohen March 10, 2026 16.80% Initial filing — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 24,530 SH Aug. 8, 2026 Daily